Supplementary Table 5 from Ganitumab (AMG 479) Inhibits IGF-II–Dependent Ovarian Cancer Growth and Potentiates Platinum-Based Chemotherapy
Year: 2023
Type: supplementary-materials
Abstract: PDF file - 53KB, IGF1R and INSR signaling in OV-90 and TOV-21G cell lines.
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4361883702
